Methyl(3r,4s)-4-methylpiperidine-3-carboxylate;hydrochloride, 98%, 250mg

Methyl 2-amino-5-bromo-3-chlorobenzoate, 98%, 1g

Sodium 2-Naphthalenesulfonate>98.0%(HPLC)(T)25g

6-(Methoxycarbonyl)-1H-indazole-3-carboxylic acid, 95.0%, 5g

7-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one, 95.0%, 2.5g

HPLC column NUCLEODUR® 100-5 C18 ec 5 µm, 250 mm, 4.6 mm, 1 Piece(s)

(3-(Pent-4-ynamido)phenyl)boronic acid, 98%, 250mg

Ethyl 2-(6-nitro-1H-indol-3-yl)-2-oxoacetate, 98%, 1g

Methyl 5-hydroxy-6-methoxypicolinate, 95.0%, 50mg

2-BENZYLOXYCYCLOBUTANONE, 95.0%, 250mg

2-Amino-3-((tert-butoxycarbonyl)amino)propanoic acid, 95+%, 500mg

Methyl (S)-2-((tert-butoxycarbonyl)amino)-2-(4-hydroxyphenyl)acetate, 98%, 10g

5-Fluoro-1-methyl-1h-indazole-3-carboxylic acid, 95+%, 100mg